BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31630867)

  • 1. NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer.
    Thomas M; Defraene G; Lambrecht M; Deng W; Moons J; Nafteux P; Lin SH; Haustermans K
    Radiother Oncol; 2019 Dec; 141():33-40. PubMed ID: 31630867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.
    Lester SC; Lin SH; Chuong M; Bhooshan N; Liao Z; Arnett AL; James SE; Evans JD; Spears GM; Komaki R; Haddock MG; Mehta MP; Hallemeier CL; Merrell KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):820-828. PubMed ID: 28476435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Kim HK; Ahn YC; Noh JM; Shim YM; Zo JI; Choi YS; Sun JM; Lee SH; Ahn MJ; Park K; Nam H
    Radiother Oncol; 2019 Apr; 133():87-92. PubMed ID: 30935586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Tucker SL; Liu HH; Wang S; Wei X; Liao Z; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):754-61. PubMed ID: 16965865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of postoperative complications after trimodality therapy for esophageal cancer.
    Wang J; Wei C; Tucker SL; Myles B; Palmer M; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z; Lin SH
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):885-91. PubMed ID: 23845841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
    Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
    Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
    Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Klevebro F; Lindblad M; Ye W; Lundell L; Nilsson M
    Br J Surg; 2014 Mar; 101(4):321-38. PubMed ID: 24493117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.
    Nederlof N; Slaman AE; van Hagen P; van der Gaast A; Slankamenac K; Gisbertz SS; van Lanschot JJ; Wijnhoven BP; van Berge Henegouwen MI;
    Ann Surg Oncol; 2016 Nov; 23(12):3964-3971. PubMed ID: 27301849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors.
    Cella L; Liuzzi R; Conson M; D'Avino V; Salvatore M; Pacelli R
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):304-10. PubMed ID: 23886419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer.
    Ferguson MK; Durkin AE
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):661-9. PubMed ID: 11986593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dosimetric factors related to postoperative pulmonary complications in locally advanced esophageal cancers treated with preoperative chemoradiotherapy: Literature review].
    Dworczak M; Le Deley MC; Adenis A; Piessen G; Lartigau É; Mirabel X; Lacornerie T; Pasquier D
    Bull Cancer; 2020 Oct; 107(10):982-990. PubMed ID: 32977935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.
    D'Journo XB; Berbis J; Jougon J; Brichon PY; Mouroux J; Tiffet O; Bernard A; de Dominicis F; Massard G; Falcoz PE; Thomas P; Dahan M
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 26730436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.
    Goense L; Meziani J; Bülbül M; Braithwaite SA; van Hillegersberg R; Ruurda JP
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30239639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Postoperative Complications following Salvage Esophagectomy for Esophageal Cancer after Definitive Chemoradiotherapy.
    Sugimura K; Miyata H; Shinno N; Ushigome H; Asukai K; Hara H; Hasegawa S; Yamada D; Yamamoto K; Haraguchi N; Nishimura J; Motoori M; Wada H; Takahashi H; Yasui M; Omori T; Ohue M; Yano M
    Oncology; 2020; 98(5):280-288. PubMed ID: 32155643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery.
    Liang Z; Luo K; Wang Y; Zeng Q; Ling X; Wang S; Dragomir MP; Li Q; Yang H; Xi M; Chen B
    Ann Surg Oncol; 2023 Jan; 30(1):529-538. PubMed ID: 36127527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a preoperative prediction model for mortality within 1 year after endovascular aortic aneurysm repair of intact aneurysms.
    Neal D; Beck AW; Eslami M; Schermerhorn ML; Cronenwett JL; Giles KA; Carroccio A; Jazaeri O; Huber TS; Upchurch GR; Scali ST
    J Vasc Surg; 2019 Aug; 70(2):449-461.e3. PubMed ID: 30922759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.
    Reinersman JM; Allen MS; Deschamps C; Ferguson MK; Nichols FC; Shen KR; Wigle DA; Cassivi SD
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):333-8. PubMed ID: 25724906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency oesophagectomy for oesophageal perforation after chemoradiotherapy for oesophageal cancer.
    Schweigert M; Solymosi N; Dubecz A; Posada Gonzalez M; Stadlhuber RJ; Ofner D; Stein HJ
    Ann R Coll Surg Engl; 2015 Mar; 97(2):140-5. PubMed ID: 25723692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.